Krystal Biotech to Present at TD Cowen 46th Annual Health Care Conference
PITTSBURGH, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS) today announced that the Company will participate in the TD Cowen 46th Annual Health Care Conference on March 3, 2026, in Boston. Company executives will take part in a fireside chat scheduled at 3:10 pm ET and host investor meetings throughout the day.
A webcast of the presentation will be available beginning at 3:10 pm ET on Tuesday, March 3, 2026 and will be posted on the Investors section of the Company’s website.
About Krystal Biotech, Inc.
Krystal Biotech, Inc. (NASDAQ: KRYS) is a fully integrated, commercial-stage, global biotechnology company focused on the discovery, development and commercialization of genetic medicines to treat diseases with high unmet medical needs. VYJUVEK
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
EU lawmakers urge assessing DeFi, staking, NFT regulation

US Spot Ethereum ETFs Extend Outflow Streak to Seven Days as BlackRock’s ETHA Leads Losses
Why July 2’s RBI Meeting Could Define India’s Crypto Path?
How a 300‑Person Stablecoin Firm Is Out‑Earning Wall Street Banks
